4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001894562-25-000051
Options or other derivatives
- Chief Technical Officer acquired 361,990 shares (grant or award)
- Chief Technical Officer returned 361,990 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| LEE ANN L. Chief Technical Officer | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −180,995 | 0 | D | ||
| LEE ANN L. Chief Technical Officer | 2025-08-01 | Grant or award · Stock Option (right to buy) | +180,995 | 180,995 | D | ||
| LEE ANN L. Chief Technical Officer | 2025-08-01 | Returned to the company · Stock Option (right to buy) | −180,995 | 0 | D | ||
| LEE ANN L. Chief Technical Officer | 2025-08-01 | Grant or award · Stock Option (right to buy) | +180,995 | 180,995 | D | ||
Loading xslF345X05/wk-form4_1754441078.xml…